Literature DB >> 6438701

An accurate and simple method for megavoltage radiation therapy of retinoblastoma.

J Schipper.   

Abstract

A simple but highly accurate irradiation method for the "conservative" treatment of retinoblastoma has been developed at the Utrecht Retinoblastoma Centre. Treatment is carried out with a 6 MV or 8 MV linear accelerator using a lateral D-shaped field of 26 X 32 mm2. This D-shaped field is specially contoured to include the entire retinal surface or vitreous and 10 mm of the anterior optic nerve and to protect the sensitive anterior structures of the eye, particularly the lens, as much as possible. Accurate positioning of the sharply collimated treatment field is easily done by magnetic fixation of the eye to the beam defining collimator by use of a low vacuum contact lens. As the fixed eye is located in the isocentre of the accelerator, the radiation beam can be directed at any angle by simple rotation of the gantry or table, without alteration of the position of the eye within the treatment field. Simultaneous irradiation of bilateral retinoblastoma is just as easily possible and can be done with the same accuracy by fixation of both eyes with contact lenses and alternately applying two opposing lateral fields. Prior to treatment, the axial dimensions of each eye are determined by ultrasonic biometry to ascertain the exact volume to be irradiated.

Entities:  

Mesh:

Year:  1983        PMID: 6438701     DOI: 10.1016/s0167-8140(83)80005-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

1.  New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma.

Authors:  E P Messmer; W Sauerwein; T Heinrich; W Höpping; D Klueter-Reckmann; N Bornfeld; H Sack; M Förster; W Havers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Radiotherapy in ophthalmology : 2004 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07       Impact factor: 3.117

3.  Long term follow-up results of external beam radiotherapy as primary treatment for retinoblastoma.

Authors:  Sang Yul Choi; Mi-Sook Kim; Sungyul Yoo; Chulkoo Cho; YoungHoon Ji; KumBae Kim; YoungSeok Seo; Kyung Duk Park; JunAh Lee; Tai-Won Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

4.  Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma.

Authors:  S M Imhof; P Hofman; K E Tan
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

5.  External beam radiotherapy for retinoblastoma: II. Lens sparing technique.

Authors:  N M Toma; J L Hungerford; P N Plowman; J E Kingston; D Doughty
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

6.  External beam radiotherapy for retinoblastoma: I. Whole eye technique.

Authors:  J L Hungerford; N M Toma; P N Plowman; J E Kingston
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

7.  Treatment of retinoblastoma and choroidal melanoma. A multidisciplinary approach.

Authors:  H A van Peperzeel
Journal:  Int Ophthalmol       Date:  1985-03       Impact factor: 2.031

Review 8.  Radiotherapy for ocular tumours.

Authors:  C Stannard; W Sauerwein; G Maree; K Lecuona
Journal:  Eye (Lond)       Date:  2012-11-23       Impact factor: 3.775

9.  Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.

Authors:  Qasiem J Nasser; Dan S Gombos; Michelle D Williams; B Ashleigh Guadagnolo; William H Morrison; Adam S Garden; Beth M Beadle; Elvia Canseco; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

10.  Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation.

Authors:  S M Imhof; A C Moll; P Hofman; M P Mourits; J Schipper; K E Tan
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.